Perspectives from those who live it every day.
In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Anne Marie Lennon from the Johns Hopkins Kimmel Cancer Center and Dr Jonathan Simons from the Marcus Foundation about a significant study that shows the majority of patients with stage II colon cancer no longer need chemotherapy following surgery.
A new mathematical model of tumorigenesis—the formation of cancer—developed by scientists at the Johns Hopkins Kimmel Cancer Center, Whiting School of Engineering, and Bloomberg School of Public Health, suggests that the accumulation of random genetic mutations that launch a cell into malignancy later in life may get their start as early as the teen years. […]
Dr Arjun Gupta discusses a 'Cancer Care Chronicles' essay he published in JAMA Oncology, titled ''Not On My Watch.'' In the essay, he shares his experiences as a first year clinical oncology fellow, while caring for a man with colon cancer. The essay is a tribute to the patient, who throughout the journey, taught Dr […]
--Two clinical trials suggest promise for using these medications in combination with other cancer therapies Two clinical trials using combinations of drugs meant to change cancer epigentics —or the way tumors express genes — failed at shrinking colon and breast tumors. However, these trials open the door for others currently in the works to combine […]
Cancer headlines this past month included two studies on colonoscopy, a screening tool for colon cancer. The first study looks at the long-term benefits of colonoscopy and found that 50 percent of colon cancer cases were avoided by a single colonscopy. In the Cancer News Review podcast, William Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer […]
Kimmel Cancer experts frequently say that “the best way to cure cancer is to prevent it from ever occurring.” Most experts agree that currently-available cancer screening tests have lead to a decline in cancer deaths. Moreover, they allow cancers to be detected early, making more treatment options available to patients. Let me say up front, […]
